Pharmaceutical company Darya-Varia Laboratoria (DVLA) booked net profit of Rp108 billion last year, an increase of 32.2% from 2014, thanks to strong sales growth of 18.3% and operating profit jump of 33% despite weaker performance in the fourth quarter.To subscribe please click here
